• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2019年全球、区域和国家早发性气管、支气管和肺癌的负担及趋势

Global, regional, and national burden and trends of early-onset tracheal, bronchus, and lung cancer from 1990 to 2019.

作者信息

Ma Jun, Song Ying-da, Bai Xiao-Ming

机构信息

Department of Thoracic Surgery, Shanxi Provincial People's Hospital, Taiyuan, China.

Fifth Clinical Medical College, Shanxi Medical University, Taiyuan, People's Republic of China.

出版信息

Thorac Cancer. 2024 Mar;15(8):601-613. doi: 10.1111/1759-7714.15227. Epub 2024 Feb 1.

DOI:10.1111/1759-7714.15227
PMID:38303633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10928250/
Abstract

BACKGROUND

Tracheal, bronchus, and lung cancer (TBL) is one of the main cancer health problems worldwide, but data on the burden and trends of early-onset tracheal, bronchus, and lung cancer (EO-TBL) are sparse. The aim of the present study was to provide the latest and the most comprehensive burden estimates of the EO-TBL cancer from 1990 to 2019.

METHODS

Overall, we used data from the Global Burden of Disease (GBD) study in EO-TBL cancer from 1990 to 2019. Evaluation metrics included incidence, mortality, and disability-adjusted life years (DALYs). The joinpoint regression model was used to analyze the temporal trends. Decomposition analysis was employed to analyze the driving factors for EO-TBL cancer burden alterations. Bayesian age-period-cohort (BAPC) analysis was used to estimate trends in the next 20 years.

RESULTS

The global age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) for EO-TBL cancer decreased significantly from 3.95 (95% uncertainty interval [UI]: 3.70-4.24), 3.41 (95% UI: 3.19-3.67), 158.68 (95% UI: 148.04-170.92) in 1990 to 2.82 (95% UI: 2.54-3.09), 2.28 (95% UI: 2.07-2.49), 106.47 (95% UI: 96.83-116.51) in 2019 with average annual percent change (AAPC) of -1.14% (95% confidence interval [CI]: -1.32 to -0.95), -1.37% (95% CI: -1.55 to -1.18), and - 1.35% (95% CI: -1.54 to -1.15) separately. The high and high-middle sociodemographic index (SDI) region had a higher burden of EO-TBL cancer but demonstrated a downward trend. The most prominent and significant upward trends were Southeast and South Asia, Africa, and women in the low SDI and low-middle SDI quintiles. At the regional and national level, there were significant positive correlations between ASDR, ASIR, ASMR, and SDI. Decomposition analysis showed that population growth and aging have driven the increase in the number of incidence, mortality, and DALYs in the global population, especially among the middle SDI quintile and the East Asia region. The BAPC results showed that ASDR, ASIR, and ASMR in women would increase but the male population remained relatively flat over the next 20 years.

CONCLUSIONS

Although global efforts have been the most successful and effective in reducing the burden of EO-TBL cancer over the past three decades, there was strong regional and gender heterogeneity. EO-TBL cancer need more medical attention in the lower SDI quintiles and in the female population.

摘要

背景

气管、支气管和肺癌(TBL)是全球主要的癌症健康问题之一,但关于早发性气管、支气管和肺癌(EO-TBL)负担及趋势的数据较为匮乏。本研究的目的是提供1990年至2019年EO-TBL癌症最新且最全面的负担估计。

方法

总体而言,我们使用了1990年至2019年全球疾病负担(GBD)研究中EO-TBL癌症的数据。评估指标包括发病率、死亡率和伤残调整生命年(DALYs)。采用连接点回归模型分析时间趋势。运用分解分析来分析EO-TBL癌症负担变化的驱动因素。采用贝叶斯年龄-时期-队列(BAPC)分析来估计未来20年的趋势。

结果

EO-TBL癌症的全球年龄标准化发病率(ASIR)、年龄标准化死亡率(ASMR)和年龄标准化DALYs率(ASDR)从1990年的3.95(95%不确定区间[UI]:3.70 - 4.24)、3.41(95% UI:3.19 - 3.67)、158.68(95% UI:148.04 - 170.92)显著下降至2019年的2.82(95% UI:2.54 - 3.09)、2.28(95% UI:2.07 - 2.49)、106.47(95% UI:96.83 - 116.51),平均年变化百分比(AAPC)分别为-1.14%(95%置信区间[CI]:-1.32至-0.95)、-1.37%(95% CI:-1.55至-1.18)和-1.3 %(95% CI:-1.54至-1.15)。高社会人口学指数(SDI)地区和高中等SDI地区的EO-TBL癌症负担较高,但呈下降趋势。最显著的上升趋势出现在东南亚、南亚、非洲以及低SDI和低中等SDI五分位数的女性群体中。在区域和国家层面,ASDR、ASIR、ASMR与SDI之间存在显著正相关。分解分析表明,人口增长和老龄化推动了全球人口中发病率、死亡率和DALYs数量的增加,尤其是在中等SDI五分位数群体和东亚地区。BAPC结果显示,在未来20年中,女性的ASDR、ASIR和ASMR将会增加,而男性人口相对保持平稳。

结论

尽管在过去三十年中全球在减轻EO-TBL癌症负担方面取得了最成功和有效的成果,但仍存在强烈的区域和性别异质性。EO-TBL癌症在较低SDI五分位数群体和女性人群中需要更多的医疗关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/11714ce328f7/TCA-15-601-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/a150b60d928e/TCA-15-601-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/c92f84c9ff45/TCA-15-601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/a1b9659dc93a/TCA-15-601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/6c64ca5aa317/TCA-15-601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/11714ce328f7/TCA-15-601-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/a150b60d928e/TCA-15-601-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/c92f84c9ff45/TCA-15-601-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/a1b9659dc93a/TCA-15-601-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/6c64ca5aa317/TCA-15-601-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba5/10928250/11714ce328f7/TCA-15-601-g004.jpg

相似文献

1
Global, regional, and national burden and trends of early-onset tracheal, bronchus, and lung cancer from 1990 to 2019.1990年至2019年全球、区域和国家早发性气管、支气管和肺癌的负担及趋势
Thorac Cancer. 2024 Mar;15(8):601-613. doi: 10.1111/1759-7714.15227. Epub 2024 Feb 1.
2
The global, regional, and national brain and central nervous system cancer burden and trends from 1990 to 2021: an analysis based on the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家脑及中枢神经系统癌症负担与趋势:基于《2021年全球疾病负担研究》的分析
Front Neurol. 2025 Jun 18;16:1574614. doi: 10.3389/fneur.2025.1574614. eCollection 2025.
3
Burden of knee osteoarthritis in China and globally: 1990-2045.中国及全球膝关节骨关节炎负担:1990 - 2045年
BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.
4
Incidence and disability-adjusted life-years of infective endocarditis in China from 1990 to 2021: comparison with G20 based on the Global Burden of Disease Study 2021.1990年至2021年中国感染性心内膜炎的发病率和伤残调整生命年:基于《2021年全球疾病负担研究》与二十国集团的比较
BMJ Open. 2025 Jul 6;15(7):e094490. doi: 10.1136/bmjopen-2024-094490.
5
Trends and gender disparities in the burden of rheumatoid arthritis in Pakistan from 1990 to 2021.1990年至2021年巴基斯坦类风湿性关节炎负担的趋势及性别差异
Sci Rep. 2025 Jul 1;15(1):21667. doi: 10.1038/s41598-025-05627-4.
6
Global, regional, and national burden, trends, and inequality analysis of maternal hypertensive disorders (MHD) from 1990 to 2021, and predictions to 2046.1990年至2021年全球、区域和国家孕产妇高血压疾病(MHD)的负担、趋势及不平等分析,以及到2046年的预测。
BMC Pregnancy Childbirth. 2025 Jul 2;25(1):680. doi: 10.1186/s12884-025-07777-9.
7
Global burden of urinary tract infections in older women from 1990 to 2021 with projections to 2040: a trend analysis of the Global Burden of Disease Study 2021.1990年至2021年老年女性尿路感染的全球负担及到2040年的预测:全球疾病负担研究2021的趋势分析
Front Cell Infect Microbiol. 2025 Jun 26;15:1577777. doi: 10.3389/fcimb.2025.1577777. eCollection 2025.
8
[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].[1990年至2021年中国及全球年龄相关性听力损失的疾病负担及未来趋势预测]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):545-553. doi: 10.19723/j.issn.1671-167X.2025.03.019.
9
Global, regional, and national burden of congenital anomalies of the kidney and urinary tract from 1990 to 2021, with projections to 2036: a systematic analysis of the global burden of disease study 2021.1990年至2021年全球、区域和国家肾脏及尿路先天性异常负担,并预测至2036年:全球疾病负担研究2021的系统分析
BMC Nephrol. 2025 Jul 1;26(1):334. doi: 10.1186/s12882-025-04269-y.
10
Global, regional, and national burden of orofacial clefts, 1990-2021: an analysis of data from the global burden of disease study 2021.1990-2021年全球、区域和国家口面部裂隙负担:基于2021年全球疾病负担研究数据的分析
Front Med (Lausanne). 2025 Jun 11;12:1609700. doi: 10.3389/fmed.2025.1609700. eCollection 2025.

引用本文的文献

1
Global respiratory tumor mortality correlation study with economic level, 2000-2019.2000 - 2019年全球呼吸道肿瘤死亡率与经济水平的相关性研究
Front Public Health. 2025 Aug 19;13:1647634. doi: 10.3389/fpubh.2025.1647634. eCollection 2025.
2
Hematological malignancy burden in mainland China and Taiwan from 1990 to 2021 and decadal projections: Insights from the global burden of disease study 2021.1990年至2021年中国大陆和台湾地区血液系统恶性肿瘤负担及十年预测:来自《2021年全球疾病负担研究》的见解
PLoS One. 2025 Jul 21;20(7):e0328526. doi: 10.1371/journal.pone.0328526. eCollection 2025.
3
A comparative analysis of the burden, trends and inequalities of tracheal, bronchus, and lung cancer in India from 2000 to 2021: A systematic analysis for the Global Burden of Disease study 2021.

本文引用的文献

1
The incidence and mortality of lung cancer in China: a trend analysis and comparison with G20 based on the Global Burden of Disease Study 2019.中国肺癌的发病率和死亡率:基于《2019年全球疾病负担研究》的趋势分析及与二十国集团的比较
Front Oncol. 2023 Aug 9;13:1177482. doi: 10.3389/fonc.2023.1177482. eCollection 2023.
2
The global burden of lung cancer: current status and future trends.全球肺癌负担:现状与未来趋势。
Nat Rev Clin Oncol. 2023 Sep;20(9):624-639. doi: 10.1038/s41571-023-00798-3. Epub 2023 Jul 21.
3
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)].
2000年至2021年印度气管、支气管和肺癌负担、趋势及不平等的比较分析:2021年全球疾病负担研究的系统分析
PLoS One. 2025 May 7;20(5):e0322646. doi: 10.1371/journal.pone.0322646. eCollection 2025.
4
Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021.早发性胰腺癌跨国不平等的时间趋势:2021年全球疾病负担研究的综合分析
Sci Rep. 2025 Apr 28;15(1):14835. doi: 10.1038/s41598-025-93892-8.
5
Global burden of TBL cancer in older adults: the role of dietary factors (1990-2021).老年人气管支气管肺癌的全球负担:饮食因素的作用(1990 - 2021年)
BMC Public Health. 2025 Apr 16;25(1):1436. doi: 10.1186/s12889-025-22377-0.
6
The benefit and risk of addition of chemotherapy to EGFR tyrosine kinase inhibitors for EGFR-positive non-small cell lung cancer patients with brain metastases: a meta-analysis based on randomized controlled trials.表皮生长因子受体(EGFR)阳性的脑转移非小细胞肺癌患者在EGFR酪氨酸激酶抑制剂基础上加用化疗的获益与风险:一项基于随机对照试验的荟萃分析
Front Oncol. 2024 Oct 21;14:1448336. doi: 10.3389/fonc.2024.1448336. eCollection 2024.
7
Trend Analysis of Lung Cancer Incidence and Mortality in Xiamen (2011-2020).厦门肺癌发病率与死亡率的趋势分析(2011 - 2020年)
Risk Manag Healthc Policy. 2024 Oct 4;17:2375-2384. doi: 10.2147/RMHP.S477529. eCollection 2024.
8
Global burden of lung cancer in women of childbearing age attributable to ambient particulate matter pollution: 1990-2021.全球 1990-2021 年归因于环境颗粒物污染的育龄期女性肺癌负担
Cancer Med. 2024 Sep;13(18):e70241. doi: 10.1002/cam4.70241.
9
Trends in lung cancer incidence in Spain (1990-2019): insights from Global Burden of Diseases data.西班牙肺癌发病率趋势(1990 - 2019年):来自全球疾病负担数据的见解
Clin Transl Oncol. 2025 Jan;27(1):189-195. doi: 10.1007/s12094-024-03555-9. Epub 2024 Jun 19.
[中国医学协会肺癌临床诊疗指南(2023年版)]
Zhonghua Zhong Liu Za Zhi. 2023 Jul 23;45(7):539-574. doi: 10.3760/cma.j.cn112152-20230510-00200.
4
A two-stage genome-wide association study identified four potential early-onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population.一项两阶段全基因组关联研究基于中国人群中的 26652 名参与者,确定了四个潜在的早发性非小细胞肺癌风险位点。
Mol Carcinog. 2023 Sep;62(9):1263-1270. doi: 10.1002/mc.23561. Epub 2023 May 26.
5
Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study.2035 年全球 40 个国家肺癌发病率预测:基于人口的研究。
JMIR Public Health Surveill. 2023 Feb 17;9:e43651. doi: 10.2196/43651.
6
The spatiotemporal dynamics of lung cancer: 30-year trends of epidemiology across 204 countries and territories.肺癌的时空动态:204 个国家和地区 30 年的流行病学趋势。
BMC Public Health. 2022 May 16;22(1):987. doi: 10.1186/s12889-022-13281-y.
7
Diet and Risk of Incident Lung Cancer: A Large Prospective Cohort Study in UK Biobank.饮食与肺癌发病风险:英国生物库大型前瞻性队列研究。
Am J Clin Nutr. 2021 Dec 1;114(6):2043-2051. doi: 10.1093/ajcn/nqab298.
8
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家的呼吸道癌症负担及相关风险因素:2019 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16.
9
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
10
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.